Attached files

file filename
EX-31.3 - EX-31.3 - Horizon Therapeutics Public Ltd Cod377184dex313.htm
EX-10.65 - EX-10.65 - Horizon Therapeutics Public Ltd Cod377184dex1065.htm
EX-10.62 - EX-10.62 - Horizon Therapeutics Public Ltd Cod377184dex1062.htm
10-K/A - FORM 10-K/A - Horizon Therapeutics Public Ltd Cod377184d10ka.htm

Exhibit 31.4

Certification of Principal Financial Officer

I, Paul W. Hoelscher, certify that:

 

  1. I have reviewed this Amendment No. 3 to the annual report on Form 10-K/A of Horizon Pharma plc; and

 

  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

 

Date: May 26, 2017
/s/ Paul W. Hoelscher                                                         
Paul W. Hoelscher
Executive Vice President, Chief Financial Officer
(Principal Financial Officer)